Morgan Stanley logo MS - Morgan Stanley

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 29
HOLD 22
SELL 1
STRONG
SELL
0
| PRICE TARGET: $239.50 DETAILS
HIGH: $260.00
LOW: $215.00
MEDIAN: $241.50
CONSENSUS: $239.50
UPSIDE: 10.64%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 90% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Overvalued Mild
Trading 4.7% above fair value
Current Price $216.47
Bear Case $144.69 33.2% downside ($144.69 - $216.47) / $216.47 = -33.2% ROTCE 14.2% → 1.47x TBV
Fair Value $206.70 4.5% downside ($206.70 - $216.47) / $216.47 = -4.5% ROTCE 19.0% → 2.15x TBV
Bull Case $268.71 24.1% upside ($268.71 - $216.47) / $216.47 = 24.1% ROTCE 21.8% → 2.56x TBV

Adjust Assumptions

19.0%
10.9%

Key Value Driver

ROTCE (19.0%) vs. cost of equity (10.9%)

Implied Market Multiple 3.84x

Plain-Language Summary

With ROTCE of 19.0% vs. 10.9% cost of equity, fair P/TBV is 2.15x on $56.36 tangible book, implying $206.70 per share. DDM cross-check: $134.03.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (52 analysts) $239.50
Analyst Range $215.00 – $260.00
Divergence from AlphaVal 14%

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Dividend-based valuation: $134.03 (35% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly